 |
|
|
| |
A Phase 1 Study Evaluating Anti-PD-1 Treatment With or
Without GS-4774 in HBeAg Negative Chronic Hepatitis B Patients
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-21 Amsterdam Netherlands
Edward J. Gane* 1, Anuj Gaggar 2, Anh Hoa Nguyen 2, G Mani Subramanian 2,
John G. McHutchison 2, Daniel Verdon 3, Christian Schwabe 1, Rod Dunbar3
1Auckland Clinical Studies, Auckland, New Zealand, 2Gilead Sciences, Inc., Foster City, California, USA, 3University of Auckland, Auckland, New Zealand
|
| |
|
|
|
|
|
